androgens - CISMeF

Preferred Label : androgens;

MeSH definition : Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.;

MeSH synonym : androgenic agents; agents, androgenic; compounds, androgenic; androgenic compounds; androgen receptor agonists; agonists, androgen receptor; receptor agonists, androgen; Androgen Receptor Agonist; Agonist, Androgen Receptor; Receptor Agonist, Androgen; Androgen;

Related MeSH term : androgen effect; Effect, Androgen; Androgen Effects; Effects, Androgen;

MeSH annotation : deficiency: consider also HYPOGONADISM & other gonadal disorders; note entry term ANDROGEN EFFECT: use only for the androgen effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Androgen;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000728;

UMLS CUI

C0002844;

ATC code(s)
- androgen, progestogen and estrogen in combination [ATC Code]
- androgens and estrogens [ATC Code]
ATC code(s)
- androgen, progestogen and estrogen in combination [ATC Code]
- androgens [ATC Code]
- androgens and estrogens [ATC Code]
- androgens and female sex hormones in combination [ATC Code]
- androgens and female sex hormones in combination with other drugs [ATC Code]
- androgens for topical use [ATC Code]
- androstanolone [ATC Code]
- mesterolone [ATC Code]
- methyltestosterone [ATC Code]
- testosterone [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Androgen [ICD-11 Extension code]
- Androgen [FMA entity]
- Androgen [NCIt concept]
- Androgen (substance) [SNOMED CT concept]
- Androgens [MedDRA Preferred Term]
- Androgens NOS [MedDRA LLT]
- Substance with androgen receptor agonist mechanism of action (substance) [SNOMED CT concept]
- androgen, nos [SNOMED Notion]
- androgens [ATC Code]
Indexing information
- 11-hydroxydihydrotestosterone [MeSH Supplementary Concept]
- 11-ketodihydrotestosterone [MeSH Supplementary Concept]
- 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester [MeSH Supplementary Concept]
- 4-(3,4-dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile [MeSH Supplementary Concept]
- 4-(4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Substance with steroid structure and androgen receptor antagonist mechanism of action (substance) [SNOMED CT concept]
MeSH Descriptor(s) used for indexing
- receptors, androgen [MeSH Descriptor]
Record concept(s)
- androgen effect [MeSH concept]
- androgens [MeSH concept]
Related MeSH term(s)
- androgen antagonists [MeSH Descriptor]
SNOMED CT : is a
- androstenediol [MeSH Descriptor]
- danazol [MeSH Descriptor]
- dehydroepiandrosterone [MeSH Descriptor]
- fluoxymesterone [MeSH Descriptor]
- mesterolone [MeSH Descriptor]
- methandriol [MeSH Descriptor]
- methandrostenolone [MeSH Descriptor]
- nandrolone [MeSH Descriptor]
- norethandrolone [MeSH Descriptor]
- oxandrolone [MeSH Descriptor]
- oxymetholone [MeSH Descriptor]
- stanozolol [MeSH Descriptor]
- testosterone [MeSH Descriptor]
See also
- androgen antagonists [MeSH Descriptor]
- receptors, androgen [MeSH Descriptor]
See also (suggested by CISMeF)
- testosterone congeners [MeSH Descriptor]
See also inter- (CISMeF)
- Androgen receptor agonist (disposition) [SNOMED CT concept]
- Therapeutic Androgen [NCIt concept]
- androgen therapy [CISMeF Querying Strategy]
Semantic type(s)
- Hormone [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 19-nortestosterone 4-hexoxyphenylpropionate [MeSH Supplementary Concept]
- 3-methyl-5-trifluoromethyl-3,4-dihydro-2H-pyrazole-3-carboxylic acid (4-cyano-3-trifluoromethylphenyl)amide [MeSH Supplementary Concept]
- LG 121071 [MeSH Supplementary Concept]
- acetothiolutamide [MeSH Supplementary Concept]
- dihydrotestosterone [MeSH Descriptor]
- nandrolone [MeSH Descriptor]
- oxandrolone [MeSH Descriptor]
- oxymetholone [MeSH Descriptor]
- stanozolol [MeSH Descriptor]
- testosterone [MeSH Descriptor]
- testosterone 17 beta-cypionate [MeSH Supplementary Concept]
- testosterone enanthate [MeSH Supplementary Concept]
- testosterone undecanoate [MeSH Supplementary Concept]
- tetrahydrogestrinone [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Androgen [FMA entity]
- Androgen [NCIt concept]
- Androgen (substance) [SNOMED CT concept]
- Androgens- [LOINC hierarchical part]
- Product containing androgen (product) [SNOMED CT concept]
- Product containing androgen receptor agonist (product) [SNOMED CT concept]
- Steroid androgenic [ICD-11 Extension code]
- Substance with androgen receptor agonist mechanism of action (substance) [SNOMED CT concept]
- Therapeutic Androgen [NCIt concept]
- androgen preparation, nos [SNOMED Notion]
- androgen, nos [SNOMED Notion]
- androgens [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients